SABBY MANAGEMENT, LLC - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 22 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$500,000
-42.2%
1,085,446
+132.0%
0.14%
-70.2%
Q3 2019$865,000
-35.3%
467,819
-0.2%
0.47%
-72.3%
Q2 2019$1,336,000468,6201.68%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 468,620$1,336,0001.68%
Anson Funds Management LP 654,762$1,866,0000.47%
Swift Run Capital 14,545$41,0000.04%
Virtu Financial LLC 11,864$34,0000.00%
Advisor Group, Inc. 940$3,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 667$2,0000.00%
WELLS FARGO & COMPANY/MN 149,875$427,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,060$28,0000.00%
DEUTSCHE BANK AG\ 200$00.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders